RVP was also associated with a significant worsening of tricuspid annular plane systolic excursion (TAPSE) (p<.0001) and S wave velocity (p<.0001) at follow up. Conversely from RVP, HBP significantly improved pulmonary artery systolic pressure (PASP) [baseline HBP 38 IQR (32-42) mmHg vs. RVP 34 IQR (31.5-37) mmHg,p=.060; 6-months HBP 32 IQR (26-38) mmHg vs. RVP 39 IQR (36-41) mmHg, p<.0001] and tricuspid regurgitation (p=.005) irrespectively from lead position above or below the tricuspid valve. In patients undergoing PM implantation, HBP ensues a beneficial and protective impact on RV performance compared with RVP. In patients undergoing PM implantation, HBP ensues a beneficial and protective impact on RV performance compared with RVP. Coronavirus disease 2019 (COVID-19) primarily causes lung infection, but recent studies have shown that cardiac involvement is associated with a worse prognosis. We conducted a systematic review and meta-analysis to examine the prevalence of cardiac arrhythmias detected by the electrocardiogram and their relationships with adverse outcomes in patients with COVID-19. PubMed and Google were searched for studies that reported on cardiac arrhythmias and/or examined the relationship between arrhythmias and adverse outcomes. Thirty studies with 12,713 participants were included in the systematic review, and 28 studies (n=12,499) in the meta-analysis. The mean age was 61.3 ± 16.8 years; 39.3% were female. In 25 studies with 7578 patients, the overall prevalence of cardiac arrhythmias was 10.3% (95% confidence interval [CI] 8.4%-12.3%). The most common arrhythmias documented during hospitalization were supraventricular arrhythmias (6.2%, 95% CI 4.4%-8.1%) followed by ventricular arrhythmias (2.5%, 95% CI 1.8%-3.1%). The incidence of cardiac arrhythmias was higher among critically ill patients (relative risk [RR] 12.1, 95% CI 8.5-17.3) and among non-survivors (RR 3.8, 95%, CI 1.7-8.7). Eight studies reported changes in the QT interval. The prevalence of QTc>500ms was 12.3% (95% CI 6.9%-17.8%). ST-segment deviation was reported in eight studies, with a pooled estimate of 8.7% (95% CI 7.3% to 10.0%). Our meta-analysis showed that QTc prolongation, ST-segment deviation, and various other cardiac arrhythmias were observed in patients hospitalized with COVID-19. https://www.selleckchem.com/products/limertinib.html The presence of cardiac arrhythmias was associated with a worse prognosis. Our meta-analysis showed that QTc prolongation, ST-segment deviation, and various other cardiac arrhythmias were observed in patients hospitalized with COVID-19. The presence of cardiac arrhythmias was associated with a worse prognosis. Oropharyngeal dysphagia is common in patients with neuromuscular diseases (NMDs). Its early recognition is vital for proper management. We tested a large cohort of adult NMD patients for oropharyngeal dysphagia using the Sydney Swallow Questionnaire (SSQ). We also looked for possible differences in characteristics of oropharyngeal dysphagia in various NMD groups and diseases. Finally, we compared results of this screening with those from their corresponding medical records for eventual "clinical history" of dysphagia. We asked patients to fill in the SSQ during follow-up outpatient visits at our neuromuscular reference center. A total score above the cutoff score of 118.5 out of 1700 was indicative of oropharyngeal dysphagia. Of the 304 adult patients assessed for eligibility, 201 NMD patients (96 women and 105 men, aged 49.0 ± 16.2 years) were included and tested in this study. Oropharyngeal dysphagia was detected in 45% of all the NMD patients when using the SSQ, whereas only 12% had a positive medical record for dysphagia. The median SSQ scores for patients with myotonic syndromes (including myotonic dystrophy type 1), with amyotrophic lateral sclerosis, and with facioscapulohumeral dystrophy were above the cutoff score. The SSQ scores obtained revealed distinct oropharyngeal dysphagia characteristics in the different NMD groups and diseases. The SSQ tests positively for oropharyngeal dysphagia in a higher proportion of NMD patients compared with their medical records. The distinct oropharyngeal dysphagia characteristics we revealed in different NMD groups and diseases may help to elaborate adapted clinical approaches in the management of oropharyngeal dysphagia. The SSQ tests positively for oropharyngeal dysphagia in a higher proportion of NMD patients compared with their medical records. The distinct oropharyngeal dysphagia characteristics we revealed in different NMD groups and diseases may help to elaborate adapted clinical approaches in the management of oropharyngeal dysphagia.Side effects are a primary reason why women stop using contraception, even though they may still want to avoid a pregnancy. The Demographic and Health Surveys (DHS), the largest source of nationally representative data on contraceptive discontinuation, only asks women who discontinued a method their reasons for discontinuation, for which side effects is an option. Yet, side effects are also experienced by continued users. Using longitudinal data collected from a cohort of contraceptive users in Odisha and Haryana, India, this study explores the effect of side effect severity and frequency on six-month discontinuation. Among women who experienced side effects of their enrollment method, 49.7 percent continued to use it by the six-month interview. Women who experienced moderate/severe side effects infrequently were 67 percent (adjusted odds ratio [AOR] 0.33; 95 percent confidence interval [CI] 0.16-0.64) less likely to discontinue the enrollment method compared to women who experienced moderate/severe side effects always. Women who experienced mild side effects were even less likely to discontinue (AOR 0.15; 95 percent CI 0.06-0.37). Study results suggest side effect severity and frequency are more important factors than simply the experience of a side effect in understanding contraceptive discontinuation. DHS and other national surveys should expand their exploration of side effects to include questions asked of current users. The low-dose computed tomography (CT) imaging can reduce the damage caused by x-ray radiation to the human body. However, low-dose CT images have a different degree of artifacts than conventional CT images, and their resolution is lower than that of conventional CT images, which can affect disease diagnosis by clinicians. Therefore, methods for noise-level reduction and resolution improvement in low-dose CT images have inevitably become a research hotspot in the field of low-dose CT imaging. In this paper, residual attention modules (RAMs) are incorporated into the residual encoder-decoder convolutional neural network (RED-CNN) and generative adversarial network with Wasserstein distance (WGAN) to learn features that are beneficial to improving the performances of denoising networks, and developed models are denoted as RED-CNN-RAM and WGAN-RAM, respectively. In detail, RAM is composed of a multi-scale convolution module and an attention module built on the residual network architecture, where the attention module consists of a channel attention module and a spatial attention module.